Results 171 to 180 of about 28,760 (185)

Screening for diabetic retinopathy: new perspectives and challenges

Lancet Diabetes and Endocrinology,the, 2020
Stela Vujosevic, Stephen J Aldington, Paolo Silva   +2 more
exaly  

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial

Lancet, The, 2019
Andreas Stahl, Domenico Lepore, Michael F Chiang   +2 more
exaly  

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

Lancet, The, 2007
Timothy Davis, Marja-Riitta Taskinen, Michael d'Emden   +2 more
exaly  

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

Lancet, The, 2008
Massimo Porta, Ronald Klein
exaly  

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

Lancet, The, 2008
Ronald Klein, Massimo Porta
exaly  

Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications

Redox Biology, 2020
Chunxue Yang
exaly  

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study

Lancet, The, 2003
Deborah M Broadbent, Jiten P Vora, Simon P Harding   +2 more
exaly  

Diabetic retinopathy

Lancet, The, 2010
Ning Cheung
exaly  

Incidence and progression of diabetic retinopathy: a systematic review

Lancet Diabetes and Endocrinology,the, 2019
Charumathi Sabanayagam, Gavin Tan, Jost B Jonas   +2 more
exaly  

Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices

Npj Digital Medicine, 2018
Michael D. Abràmoff, James C Folk
exaly